Weight Loss in HIV/HCV-Coinfected Patients
In a study of 47 HIV/HCV-coinfected patients, treatment with antiretrovirals and interferon + ribavirin was associated with moderate weight loss and with amylase and lactate elevations.
Welcome to Journal Watch. The content you requested requires sign in with a username and password.
Sign In
Sign Up
Print subscribers
Activate your free online account for full access to all site content and features.
Other visitors
Subscribe for full access to all site content and features. ($99/year)
Purchase a site pass for full access to all articles. ($19/7 days)
Or, simply register for free access to email alerts, site features, and article archives. (FREE)